| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.062 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |